H2 Equity Partners to acquire William Blythe from Synthomer for £30m.

H2 Equity Partners, a private equity firm, agreed to acquire William Blythe, a chemical solutions provider, from Synthomer, a global differentiated chemicals company, for £30m. "Today's announcement recognises William Blythe's unique attributes and strong performance over many years as part of Synthomer. With the divestment to the ambitious management team backed by H2 Equity Partners, I am confident this is a win-win transaction for all involved and wish all our William Blythe colleagues well for the next exciting chapter in its long history," Michael Willome, Synthomer CEO.